Home > Comparison > Industrials > ESAB vs PRLB
The strategic rivalry between ESAB Corporation and Proto Labs, Inc. shapes the industrial metal fabrication sector’s future. ESAB operates as a capital-intensive manufacturer of welding and cutting equipment, serving diverse heavy industries. Proto Labs, by contrast, leads as a high-tech, e-commerce-driven digital manufacturer specializing in rapid prototyping and custom parts. This analysis will evaluate which company’s operational approach delivers superior risk-adjusted returns for a diversified portfolio.
Table of contents
Companies Overview
ESAB Corporation and Proto Labs, Inc. hold pivotal roles in the manufacturing sector with distinct value propositions and market approaches.
ESAB Corporation: Leader in Welding and Cutting Solutions
ESAB Corporation dominates the metal fabrication equipment market, generating revenue through consumables and welding machinery sales. Its core strength lies in welding consumables and automated cutting systems. In 2026, ESAB emphasizes digital integration, offering software solutions to boost productivity and remote monitoring in industrial operations.
Proto Labs, Inc.: Digital Manufacturer for Rapid Prototyping
Proto Labs, Inc. excels as an e-commerce driven digital manufacturer, specializing in custom prototypes and on-demand production parts. Its revenue derives from advanced services like 3D printing, CNC machining, and sheet metal fabrication. The company focuses on expanding its quick-turn manufacturing capabilities to serve engineers globally in 2026.
Strategic Collision: Similarities & Divergences
Both firms serve metal fabrication but diverge sharply in business philosophy. ESAB relies on a closed ecosystem of hardware and software, while Proto Labs champions an open, digital-first manufacturing platform. They compete primarily in serving industrial customers requiring precision parts and welding solutions. Their investment profiles differ: ESAB offers stability through legacy industrial products, whereas Proto Labs provides growth potential in digital manufacturing innovation.
Income Statement Comparison
This data dissects the core profitability and scalability of ESAB Corporation and Proto Labs, Inc. to reveal who dominates the bottom line:
| Metric | ESAB Corporation (ESAB) | Proto Labs, Inc. (PRLB) |
|---|---|---|
| Revenue | 2.74B | 533M |
| Cost of Revenue | 1.70B | 296M |
| Operating Expenses | 590M | 212M |
| Gross Profit | 1.04B | 237M |
| EBITDA | 531M | 65M |
| EBIT | 465M | 31M |
| Interest Expense | 65M | 0 |
| Net Income | 265M | 21M |
| EPS | 4.36 | 0.89 |
| Fiscal Year | 2024 | 2025 |
Income Statement Analysis: The Bottom-Line Duel
The following income statement comparison reveals which company runs a more efficient and profitable corporate engine through recent market cycles.
ESAB Corporation Analysis
ESAB’s revenue grew 40.55% over five years but dipped 1.22% in 2024, showing slight top-line pressure. Net income surged 68.25% overall with a 30.61% margin expansion in 2024, reflecting robust earnings momentum. Gross margin at 37.85% and net margin near 9.66% demonstrate strong operational control and solid profitability.
Proto Labs, Inc. Analysis
Proto Labs posted modest revenue growth of 9.23% over five years and a 6.44% rise in 2025, indicating steady top-line progress. However, net income declined 36.35% overall despite a 20.27% net margin improvement last year. Gross margin remains healthy at 44.48%, but the net margin at 3.98% reveals pressure on translating sales into profits.
Margin Strength vs. Earnings Resilience
ESAB delivers stronger net margins and robust earnings growth compared to Proto Labs, which shows weaker profitability despite higher gross margins. ESAB’s consistent margin expansion and 68% net income growth affirm its superior income statement efficiency. For investors prioritizing durable earnings and margin resilience, ESAB’s profile stands out as the more attractive foundation.
Financial Ratios Comparison
These vital ratios act as a diagnostic tool to expose the underlying fiscal health, valuation premiums, and capital efficiency of each company:
| Ratios | ESAB Corporation (ESAB) | Proto Labs, Inc. (PRLB) |
|---|---|---|
| ROE | 15.0% | 3.2% |
| ROIC | 10.3% | 2.6% |
| P/E | 27.4 | 57.0 |
| P/B | 4.10 | 1.80 |
| Current Ratio | 1.82 | 3.49 |
| Quick Ratio | 1.18 | 3.27 |
| D/E (Debt-to-Equity) | 0.66 | 0.007 |
| Debt-to-Assets | 29% | 0.6% |
| Interest Coverage | 6.90 | 0 (not reported) |
| Asset Turnover | 0.68 | 0.70 |
| Fixed Asset Turnover | 7.06 | 2.47 |
| Payout ratio | 6.4% | 0% |
| Dividend yield | 0.23% | 0% |
| Fiscal Year | 2024 | 2025 |
Efficiency & Valuation Duel: The Vital Signs
Ratios act as a company’s DNA, exposing hidden risks and operational excellence critical for investment decisions.
ESAB Corporation
ESAB delivers a solid 15% ROE and a favorable 10.3% ROIC, indicating efficient capital use above its 8.77% WACC. However, its stretched valuation with a 27.4 P/E and high 4.1 P/B ratios suggests premium pricing. Shareholder returns include a modest 0.23% dividend yield, reflecting cautious capital distribution amid stable operations.
Proto Labs, Inc.
Proto Labs shows weaker profitability, with a low 3.2% ROE and 2.6% ROIC, both unfavorable compared to its 9.81% WACC. Its valuation appears stretched at a 57 P/E but a more reasonable 1.8 P/B. The company pays no dividend, signaling reinvestment into R&D and growth to support future gains despite current margin pressures.
Premium Valuation vs. Operational Safety
ESAB balances profitability and capital efficiency well but trades at a premium, reflecting confidence in stable returns. Proto Labs faces profitability challenges and a higher valuation multiple, relying on growth reinvestment. Investors seeking operational safety may prefer ESAB, while growth-focused profiles might tolerate Proto Labs’ riskier setup.
Which one offers the Superior Shareholder Reward?
I observe ESAB Corporation pays a modest dividend yield near 0.23%, covered comfortably by free cash flow with a low payout ratio around 6.4%. ESAB complements this with steady share buybacks, supporting total shareholder return. Proto Labs, Inc. pays no dividend but aggressively reinvests in growth, R&D, and acquisitions, maintaining strong cash flow and minimal debt. Its buybacks are limited, prioritizing expansion over distributions. Historically, ESAB’s balanced distribution via dividends and buybacks offers more immediate shareholder reward, while Proto Labs targets capital appreciation with higher risk. For 2026 investors seeking sustainable income plus buyback-driven upside, ESAB presents a more attractive total return profile.
Comparative Score Analysis: The Strategic Profile
The radar chart reveals the fundamental DNA and trade-offs of ESAB Corporation and Proto Labs, Inc., highlighting their financial strengths and valuation nuances:
ESAB shows a balanced performance in DCF, ROE, and ROA, but struggles with debt and valuation metrics. Proto Labs excels in debt management with a top Debt/Equity score but has a weaker ROE and very unfavorable P/E valuation. ESAB relies on operational efficiency, while Proto Labs leverages financial stability and conservative leverage.
Bankruptcy Risk: Solvency Showdown
Proto Labs’ Altman Z-Score of 11.76 places it well within the safe zone, indicating robust long-term survival prospects. ESAB’s 2.85 score positions it in the grey zone, signaling moderate bankruptcy risk under current market pressures:
Financial Health: Quality of Operations
Proto Labs’ Piotroski F-Score of 7 indicates strong financial health and operational efficiency. ESAB’s score of 5 is average, suggesting some internal red flags and room for improvement in profitability and liquidity metrics:
How are the two companies positioned?
This section dissects ESAB and PRLB’s operational DNA by comparing their revenue distribution and internal strengths and weaknesses. The goal is to confront their economic moats to reveal which business model offers the most resilient competitive advantage today.
Revenue Segmentation: The Strategic Mix
This visual comparison dissects how ESAB Corporation and Proto Labs, Inc. diversify their income streams and where their primary sector bets lie:
ESAB leans heavily on Equipment Products, generating $1.85B in 2024, nearly doubling its Consumable Products at $893M. Proto Labs displays a more balanced spread, with Injection Molding leading at $194M, followed closely by CNC Machining at $207M and 3D Printing at $84M. ESAB’s focus signals infrastructure dominance but exposes it to concentration risk. Proto Labs’ diversified portfolio pivots on multiple advanced manufacturing technologies, enhancing resilience and cross-market appeal.
Strengths and Weaknesses Comparison
This table compares the strengths and weaknesses of ESAB Corporation and Proto Labs, Inc.:
ESAB Strengths
- Balanced product portfolio with strong Equipment and Consumables segments
- Global sales split between Americas and EMEA/APAC supports geographic diversification
- Favorable ROIC above WACC indicates efficient capital use
- Solid liquidity ratios and low debt-to-assets ratio
- High fixed asset turnover reflects operational efficiency
PRLB Strengths
- Diverse manufacturing technologies including 3D printing, CNC machining, and injection molding
- Favorable debt-to-assets and interest coverage ratios signal financial stability
- Presence in the US and Europe markets shows geographic reach
- Favorable quick ratio supports near-term liquidity
- Moderate asset turnover suggests operational consistency
ESAB Weaknesses
- PE and PB ratios are unfavorable, indicating potential overvaluation risk
- Dividend yield is low, possibly limiting income appeal
- Net margin and ROE are neutral, showing moderate profitability
- Moderate debt levels could constrain financial flexibility
PRLB Weaknesses
- Low profitability metrics (net margin, ROE, ROIC) highlight weak earnings performance
- PE ratio is high, suggesting valuation concerns
- Current ratio unfavorable despite quick ratio strength, indicating working capital management issues
- Zero dividend yield may deter income-focused investors
Overall, ESAB shows stronger profitability and operational efficiency, supported by balanced geographic and product diversification. PRLB faces challenges in profitability and valuation but maintains a diverse product mix and strong liquidity. These factors shape each company’s strategic financial priorities going forward.
The Moat Duel: Analyzing Competitive Defensibility
A structural moat shields long-term profits from relentless competitive pressure. Without it, market share and margins erode quickly:
ESAB Corporation: Industrial Scale & Technological Integration Moat
ESAB’s moat stems from its specialized welding equipment and digital solutions, enabling stable margins and rising profitability. Its expanding automation offerings could widen this moat in 2026.
Proto Labs, Inc.: Digital Manufacturing Agility Moat
Proto Labs leverages rapid e-commerce-driven custom manufacturing, contrasting ESAB’s industrial scale. However, its declining ROIC signals weakening competitive leverage despite growth opportunities in 3D printing.
Verdict: Industrial Scale vs. Agile Manufacturing — Who Defends Profitability Better?
ESAB exhibits a deeper moat with improving ROIC and margin stability, while Proto Labs’ declining profitability warns of value destruction. ESAB is better positioned to defend its market share long-term.
Which stock offers better returns?
Both ESAB Corporation and Proto Labs, Inc. display strong upward price trends over the past year, marked by significant gains and active buyer dominance in recent months.
Trend Comparison
ESAB Corporation’s stock rose 34.8% over the past year, showing a bullish trend with accelerating momentum and a high near 134.05. Volatility measures 10.57, indicating moderate price fluctuations.
Proto Labs, Inc. delivered a 97.04% gain over the same period, also bullish with acceleration. Its volatility is slightly lower at 8.43, with the highest price reaching 67.17, suggesting strong performance with steadier moves.
Comparing both, Proto Labs outperformed ESAB by a wide margin, nearly tripling ESAB’s gains, thus delivering the highest market return among the two stocks.
Target Prices
Analysts present a clear consensus on target prices for ESAB Corporation and Proto Labs, Inc.
| Company | Target Low | Target High | Consensus |
|---|---|---|---|
| ESAB Corporation | 140 | 149 | 145.4 |
| Proto Labs, Inc. | 34 | 44 | 38.5 |
The consensus target for ESAB stands about 8% above the current price of 134, indicating moderate upside. Proto Labs’ target consensus is significantly below its current price of 67, suggesting potential downside or market overvaluation.
Don’t Let Luck Decide Your Entry Point
Optimize your entry points with our advanced ProRealTime indicators. You’ll get efficient buy signals with precise price targets for maximum performance. Start outperforming now!
How do institutions grade them?
ESAB Corporation Grades
The following table summarizes recent institutional grades for ESAB Corporation.
| Grading Company | Action | New Grade | Date |
|---|---|---|---|
| JP Morgan | Maintain | Overweight | 2026-02-03 |
| Roth Capital | Maintain | Buy | 2026-02-03 |
| Oppenheimer | Maintain | Outperform | 2026-01-23 |
| Stifel | Maintain | Buy | 2026-01-23 |
| JP Morgan | Maintain | Overweight | 2026-01-14 |
| Stifel | Maintain | Buy | 2025-12-16 |
| JP Morgan | Maintain | Overweight | 2025-10-30 |
| UBS | Maintain | Buy | 2025-10-20 |
| JP Morgan | Maintain | Overweight | 2025-10-14 |
| Loop Capital | Upgrade | Buy | 2025-08-22 |
Proto Labs, Inc. Grades
The following table summarizes recent institutional grades for Proto Labs, Inc.
| Grading Company | Action | New Grade | Date |
|---|---|---|---|
| Benchmark | Maintain | Buy | 2025-11-03 |
| Cantor Fitzgerald | Maintain | Overweight | 2025-08-01 |
| Cantor Fitzgerald | Maintain | Overweight | 2025-02-10 |
| Needham | Maintain | Hold | 2025-02-07 |
| Needham | Maintain | Hold | 2025-01-16 |
| Cantor Fitzgerald | Maintain | Overweight | 2024-11-04 |
| Craig-Hallum | Maintain | Hold | 2024-11-04 |
| Cantor Fitzgerald | Maintain | Overweight | 2024-07-30 |
| Benchmark | Maintain | Buy | 2024-05-29 |
| Craig-Hallum | Maintain | Hold | 2024-05-06 |
Which company has the best grades?
ESAB Corporation consistently earns strong buy-side ratings, including multiple “Buy” and “Overweight” grades. Proto Labs displays a mixed profile with several “Hold” ratings. Investors may perceive ESAB as having a more favorable institutional outlook.
Risks specific to each company
The following categories identify the critical pressure points and systemic threats facing both firms in the 2026 market environment:
1. Market & Competition
ESAB Corporation
- Operates in a competitive metal fabrication sector with steady demand across industries. Faces pressure from automation rivals.
Proto Labs, Inc.
- Digital manufacturing niche with fast innovation cycles. Intense competition from both traditional and tech-driven manufacturers.
2. Capital Structure & Debt
ESAB Corporation
- Moderate leverage (D/E 0.66) with favorable interest coverage (7.16x), showing balanced debt risk.
Proto Labs, Inc.
- Near debt-free (D/E 0.01), minimizing financial risk and interest burden significantly.
3. Stock Volatility
ESAB Corporation
- Beta at 1.205 indicates moderate sensitivity to market swings, with steady volume.
Proto Labs, Inc.
- Higher beta of 1.285 signals more volatility, amplified by thin average volume relative to recent spikes.
4. Regulatory & Legal
ESAB Corporation
- Exposure to industrial manufacturing regulations and safety compliance in diverse sectors.
Proto Labs, Inc.
- Faces evolving rules on digital manufacturing, IP protections, and environmental standards.
5. Supply Chain & Operations
ESAB Corporation
- Relies on global raw materials and distributors, vulnerable to supply disruptions.
Proto Labs, Inc.
- Digital model lowers inventory risk but depends on advanced machinery and tech suppliers.
6. ESG & Climate Transition
ESAB Corporation
- Industrial footprint requires ongoing investments in emissions control and energy efficiency.
Proto Labs, Inc.
- Positioned to benefit from sustainability trends via digital fabrication but must manage energy use of 3D printing processes.
7. Geopolitical Exposure
ESAB Corporation
- Global sales expose it to trade tensions and tariffs, especially in energy and infrastructure markets.
Proto Labs, Inc.
- Primarily US-based operations reduce direct geopolitical risk but global customers add indirect exposure.
Which company shows a better risk-adjusted profile?
ESAB’s most significant risk is market competition and supply chain vulnerability, while Proto Labs faces pronounced stock volatility and weaker profitability. Despite Proto Labs’ near-zero leverage and strong bankruptcy scores, its unfavorable profitability metrics and high P/E ratio raise concerns. ESAB’s balanced capital structure and favorable operational ratios create a more stable risk-return profile in 2026.
Final Verdict: Which stock to choose?
ESAB Corporation’s superpower lies in its steadily improving profitability and efficient capital use, signaling a company on a path to value creation. Its point of vigilance is a relatively high valuation multiple, which might pressure returns if growth slows. ESAB suits investors seeking stable growth with a slight margin of safety.
Proto Labs, Inc. commands a strategic moat through its robust balance sheet and operational agility, reflected in a strong current ratio and minimal debt. However, its declining profitability and higher valuation risk temper enthusiasm. PRLB fits portfolios targeting GARP, balancing growth potential with prudent risk management.
If you prioritize consistent value creation and a proven ability to enhance returns on invested capital, ESAB outshines as the compelling choice. However, if you seek growth with a strong financial safety net and can tolerate some earnings volatility, PRLB offers better stability. Each appeals to distinct investor profiles with different risk appetites and time horizons.
Disclaimer: Investment carries a risk of loss of initial capital. The past performance is not a reliable indicator of future results. Be sure to understand risks before making an investment decision.
Go Further
I encourage you to read the complete analyses of ESAB Corporation and Proto Labs, Inc. to enhance your investment decisions:
